mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.5 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.5 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.5 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |